WCA 2014 -Main Topics

Track I: 
Adult: Knowledge Translating
.     Track II: 
Asthma Knowledge Translating
.     Track III: 
Paediatric Programme
  • Asthma: a disease of many phenotypes
  • Asthma in the elderly
  • Occupational asthma
  • Asthma and obesity: what is the relationship?
  • Biomarkers of treatment responses
  • Links between astma and rhinitis
  • Upper airway influences on lower airways
  • Basic principles of guidelines implementation
  • Translation of GINA strategy into care
  • How to address care gaps in primary care
  • Emergency approach to asthma attacks in adults
  • Management of asthma in pregnancy
  • Adherence to Treatment in Allergy, Asthma & COPD: a neglected issue.
  • COPD Treatments as future Asthma Treatment
  • Fixed airflow obstruction in Asthma: pathological basis and consequences for treatment
  • Inhaled corticosteroids: different mechanisms and efficacy in Asthma and COPD
  • LAMA in Asthma: only for patients with severe poorly reversible airflow obstruction?
  • Triple therapy (ICS + LABA + LAMA) popular in COPD but forbidden in Asthma?
  • Tobacco in asthma and rhinitis
  • Knowledge Translation in Health Care: from evidence to practice


  • Monoclonal antibodies
  • New COPD Treatments
  • PROTEOMICS: a step forward in understanding Asthma
  • Severe Asthma: a different phenotype or different phenotypes?
  • Genetic factors and epigenetics
  • How does epithelial integrity protect against environmental insults
  • Breakdown in epithelial protection in Rhinosinusitis
  • Role of component resolved diagnostics
  • Subphenotyping and endotyping asthma
  • Diagnostic genetic scores in personalising diagnoses of allergy and asthma
  • Pharmacogenetics in deciding treatment options
  • Biodiversity and allergic disease
  • What is climate change doing to our environment in relation to allergy trends?
  • The changing microbiome and allergy
  • Smoking Cessation – Essential part of asthma treatment
  • The role of infection in asthma exacerbations
  • New biologic agents for treating severe asthma
  • A Novel paradigm for generating relevant evidence for guidelines: real life trials
  • Clusters and biomarkers of severe asthma in adults
  • Allergens in acute asthma exacerbations


  • Chronic rhinosinusitis and asthma in childhood. How to deal with it?
  • Prenatal and early life gene/ environmental programming
  • Predictive risk of rhinitis for asthma in children
  • Allergic and non allergic rhinitis in children under 5: implications for care
  • Severe Paediatric asthma
  • Risk factors for wheezing/asthma in infants
  • Asthma and obesity: association or epiphenomenon
  • Pulmonary function in infants and its contribution for the diagnosis of asthma
  • Allergens and/or virus and/or allergens in the development of asthma: the chicken or the egg dilemma
  • Managing severe asthma in childhood
  • Lung function decline: when does it start?
  • Are COPD starting in infants?
  • The MEDALL project: mechanisms of allergy
  • PAPA: Prevention of Allergy, Prevention of Asthma
  • Measuring lung function in children
  • Inflammatory markers of asthma and children
  • Genome-wide association influencing allergic sensitization
  • The aerosol therapy and lung deposition in children
  • What is the role of bacteria in airway inflammation and wheezing?